10/09/2024
3:07 PM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
1:14 PM | 10x Genomics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
09/04/2024
4:34 PM | 10x Genomics (Issuer)
Teichmann Sarah A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:03 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:04 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:05 PM | 10x Genomics (Issuer)
10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:39 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/22/2024
7:42 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
7:45 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
10:16 AM | 10x Genomics (Subject)
ARK Investment Management LLC (Filed by)
| Form SC 13G | |
07/19/2024
3:42 PM | 10x Genomics (Issuer)
Teichmann Sarah A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2024
3:48 PM | 10x Genomics (Issuer)
MATEO ALAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/13/2024
3:08 PM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
8:55 AM | 10x Genomics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
05/23/2024
6:52 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:53 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:54 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:23 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:27 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:17 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
3:23 PM | 10x Genomics (Filer)
| Form PRE 14A | |
03/25/2024
4:15 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:16 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:17 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
6:02 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:40 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:19 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
5:59 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:06 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
3:20 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:33 PM | 10x Genomics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/09/2024
7:35 AM | 10x Genomics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
1:08 PM | 10x Genomics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/29/2024
10:43 AM | 10x Genomics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/18/2024
3:49 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:08 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:00 AM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:17 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:19 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:43 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:09 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
12/08/2023
3:37 PM | 10x Genomics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
11/27/2023
5:16 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:18 PM | 10x Genomics (Issuer)
Wilbur James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:15 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:15 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:25 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:25 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:29 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:30 PM | 10x Genomics (Issuer)
Wilbur James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
5:08 PM | 10x Genomics (Subject)
Wilbur James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
3:22 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:33 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
